Related Experiment Video
Updated: May 21, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
Published on: December 8, 2023
Immunogenicity and immunoprotective potential of recombinant OmpC and TrxA-OmpC from Vibrio parahaemolyticus
Jiaqi Feng1, Wen Li1, Wentao Zhu1
1Jiangsu Key Laboratory of Marine Bioresources and Environment, Jiangsu Ocean University, Lianyungang, Jiangsu, China; Co-Innovation Center of Jiangsu Marine Bio-industry Technology, Jiangsu Ocean University, Lianyungang, Jiangsu, China; Jiangsu Key Laboratory of Marine Biotechnology, Jiangsu Ocean University, Lianyungang, Jiangsu, China.
Abstract:
Studies exploring the potential of outer membrane protein C (OmpC) as a vaccine candidate and diagnostic antigen for Vibrio parahaemolyticus remain limited. In this study, native OmpC and a thioredoxin-fused form (TrxA-OmpC) were successfully expressed in a prokaryotic system and evaluated for their surface exposure and immunogenicity. Surface accessibility of OmpC in the presence of bacterial surface polysaccharides was investigated using antisera raised against polysaccharide-deficient mutant strains. Immune responses induced by both recombinant proteins were assessed through immunoassays, Western blotting, and serum bactericidal assays. The results demonstrated that although surface polysaccharides partially masked OmpC epitopes, OmpC remained accessible on the bacterial surface. Both OmpC and TrxA-OmpC induced strong antibody responses with high titers (27K-729K) and showed cross-reactivity with V. parahaemolyticus and two other Vibrio species. Moreover, antisera against TrxA-OmpC exhibited stronger antibody-dependent bactericidal activity at a serum dilution of 1:8, compared with 1:2 for OmpC antisera. These findings suggest that OmpC is an immunogenic surface antigen with promising in vitro bactericidal activity, although its in vivo protective efficacy requires further investigation.
More Related Videos
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022